Edition:
United Kingdom

BioScrip Inc (BIOS.OQ)

BIOS.OQ on NASDAQ Stock Exchange Global Select Market

3.00USD
19 Jan 2018
Change (% chg)

$0.01 (+0.33%)
Prev Close
$2.99
Open
$2.99
Day's High
$3.05
Day's Low
$2.96
Volume
159,758
Avg. Vol
263,721
52-wk High
$3.39
52-wk Low
$1.21

Select another date:

Tue, Nov 28 2017

BRIEF-BioScrip Announces Additions To Senior Leadership Team

* BIOSCRIP - ‍ANNOUNCED APPOINTMENTS OF HARRIET BOOKER AS CHIEF OPERATING OFFICER, DANNY CLAYCOMB AS SENIOR VICE PRESIDENT, REVENUE CYCLE MANAGEMENT​ Source text for Eikon: Further company coverage:

BRIEF-BioScrip can now dispense & administer radicava treatment option for amyotrophic lateral sclerosis

* BioScrip says can now dispense & administer Radicava (edaravone) treatment option for amyotrophic lateral sclerosis approved by U.S. FDA Source text for Eikon: Further company coverage:

BRIEF-Coliseum Capital reports 14.6 pct stake in Bioscrip

* Coliseum Capital Management LLC reports 14.6 percent stake in Bioscrip Inc as of September 7, 2017 - SEC filing‍​

BRIEF-BioScrip qtrly loss per share $0.26

* Q2 revenue $218.1 million versus I/B/E/S view $220.2 million

Select another date: